Brooklyn ImmunoTherapeutics (BTX) Stock Spikes To Surpass Its New Highs

The Brooklyn ImmunoTherapeutics Inc (NYSEAMERICAN:BTX) stock had fallen at different points during the past two trading sessions, however, this morning; it has managed to clock gains of 55% so far.

Brooklyn ImmunoTherapeutics (BTX) Stock Spikes To Surpass Its New Highs

There has been no fresh news about the company this morning but it should be noted that the Brooklyn stock had been the target of the Reddit investors’ community WallStreetBets earlier on this week. The rally in the stock came about on Wednesday on the back of speculation about a short squeeze from WallStreetBets investors.

Related:  Atossa Therapeutics (ATOS) stock Moves Up Again: How To Trade Now?

The stock had rallied strongly on Wednesday and that had given rise to the speculation. Apparently, users in the WallStreetBets community had discussed the possibility of targeting biotech stocks and Brooklyn ImmunoTherapeutics might be one of those targets. It should be noted that the company is a fairly new one and had only been formed in March following a reverse merger that involved NTN Buzztime Inc. Investors could keep an eye on this stock today.

BTX stock is now up by 54.30% at $53.08 after hitting a new high of 59.59 earlier in the session.

Alex Krakowsky

Editor in Chief. Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life